The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...
The regulator cited deficiencies at a third-party manufacturing facility. Camurus is seeking approval for its ...
The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...
The FDA has granted a de novo clearance to a new type of stent designed to hold open the passages down the windpipe and into ...
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent ...
Gorji joined DLA Piper, one of the biggest law firms in the world, as a litigation partner, adding to its FDA team, which ...
The FDA handed a CRL to the Swedish biotech Camurus for its hormone disorder therapy over “facility-related deficiencies” at ...
The withdrawal of the FDA accelerated approval for locally advanced or metastatic urothelial carcinoma, a type of bladder ...
Rhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance related to design changes made to its ...
The U.S. Food and Drug Administration (FDA) has issued a Class I recall for a line of milk products as they may contain undeclared almonds from almond milk, a known allergen. The firm-initiated recall ...